The Weekly Bioanalysis - An Official Podcast of KCAS

It’s an extra special episode of “The Weekly Bioanalysis” as Dom and John celebrate the 50th EPISODE of the official KCAS Podcast by greeting you LIVE in front of the cameras in person for the first time! To watch the video version of the episode, visit this link on KCAS's website: https://kcasbio.com/blog/twb-050 As usual, they discuss the news, the industry, and other topics like their rece...

This episode Don and John thought they would talk about something near and dear to our hearts here at KCAS - Antibody-Drug Conjugates. Increasingly we’ve all experienced talk about ADCs everywhere being approved and for various conditions - mostly oncology (drugs used in the treatment of cancer). And of course the point of an ADC is to use the ability of the antibody to deliver an otherwise very t...

Sonia Hall, PhD, the CEO of BioKansas, joins Dom and John as our guest for the 49th episode of "The Weekly Bioanalysis". Among a litany of topics, Sonia takes the time to tell the guys about all the amazing things BioKansas does and she gives a breakdown of the many upcoming events planned for the next few months. Both Dom and John are big fans of BioKansas and you can just tell in their...

One of the biggest questions on so many people’s minds since the beginning of 2020 has been “how long will it take for an official vaccine to be approved by the FDA?”. It seems the answer has arrived in the form of the approval by the FDA for Pfizer’s COVID-19 Vaccine. Of course, the same vaccine (as well as a number of others) have already been in use for months now, so what exactly is the differ...

Dom and John have had a busy summer, and due to recent pressing issues, episode #46 of “The Weekly Bioanlaysis” is an abbreviated version, focusing only on a review of recent news and resources within the industry. Our next episode #47 will focus on the recent announcement that Pfizer’s COVID vaccine has been officially approved by the FDA. Please come back and check that one out – and as always –...

Dom and John often like to feature each of the groups within our industry that contribute to the success of the team, and recently, one of those groups that they were asked about was Program Management. Both of them see first hand the benefit of having a dedicated program management team at a CRO like KCAS, and while we have often showcased others within our organization, it felt like it was time...

A number of COVID variants have popped up throughout the life of our podcast, but we’re all hearing more and more stories coming out about the struggles and new challenges surrounding the Delta variant. Despite the encouraging rise in the number of vaccinated, a number of countries have seen an alarming spread of the Delta variant, leading to concern around the globe. For episode #44 of “The Weekl...

Apologies from the Producer for the shorter length of this episode. We had planned to air a recorded podcast episode on a topic we already knew had the potential to become somewhat controversial, but as the news on this topic progressed between the time of recording and publishing of this episode, we all felt the nature of the material was best left shelved – at least for the moment. Perhaps somed...

As more and more of America (and the world) become fully vaccinated, there are still many questions from everyone, regardless of whether they have been vaccinated. For the 42nd episode of “The Weekly Bioanalysis” podcast, Dom and John discuss many of these questions by giving a sort of “State of Play” with COVID vaccines, as well as looking ahead at what’s next for Vaccines – and even what the “ne...

During episode #41 of “The Weekly Bioanalysis”, Dom and John discuss the often sensitive topic of the need for regulation and oversight within the pharma and biopharma industries during testing, manufacturing and clinical trials. The evidence for these things has been made clear many times over the years, but even within the past few weeks, there have been news stories that continue to showcase th...

2020 had an impact on nearly every industry around the world in 2021, with effects that will likely continue to ripple well into 2022 and possibly the years beyond. Arguably one of the industries that saw the largest shifts related directly to the events of 2020 were the Pharma and Biopharma sectors. From public perception to investor interest, the unprecedented events had a number of impacts on o...

During episode 39 of "The Weekly Bioanalysis", Dom and John are joined by one of our KCAS colleagues, Mallory Jolly. Mallory is our newest Business Development Representatives, and while she has an extensive background within the industry, she found it occasionally difficult to describe the nuances and particulars that set Bioanalysis apart from the rest of the Pharma and Biopharma indus...

There are SO many conversations being had about Vaccines right now. In fact its difficult to find a social media stream that doesn't include at least one photo of someone's recently stamped vaccine confirmation paperwork. Everyone is asking "Which one did you get?", "When will my final dose take its full effect?", "Are some vaccines 'better' than others...

During episode 37, Dom and John are joined by Stephanie Pasas-Farmer, Founder and CEO of Adriadne Software, as we look back over the things our industry has learned about the limitations of the Drug Development Process during COVID. Stephanie and John Pirro, Sr Director of LBA Development at KCAS, discuss the importance of managing processes and how the right software plays a role in facilitating....

During the 36th episode of “The Weekly Bioanalysis”, Dom and John touch on something they really haven't yet throughout the course of our podcast - the impact of trends within the drug development industry on consumer costs. There is a very clear course most drugs take throughout their process, but minor changes in industry trends can affect the final outcomes of those steps - and ultimately...

On the heels of vaccine production and distribution over the past month or so, there has been a lot of talk in the news about Covid variants and what this might mean for infection rates, vaccine implications and what might be next in terms of therapies and treatments. Dom and John examine some of these observations during the 35th episode of “The Weekly Bioanalysis” to discuss a number of the vari...

Ever since the first COVID vaccine was approved a few weeks ago, everyone has been talking about them. As the FDA (U.S. Food and Drug Administration) issues more and more authorizations and vaccination gets underway, Dom and John take some time to discuss the Top 10 current vaccine and therapeutics manufacturers in the fight against COVID. "The Weekly Bioanalysis" is a podcast dedicated...

For episode #33 of the "The Weekly Bioanalysis" podcast, Dom and John look forward to 2021, and make their predictions for drug development in both COVID and Non-COVID realms. "The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every week, KCAS will bring...

For episode #32 of the "The Weekly Bioanalysis" podcast, Dom and John discuss the effect of COVID on 2020 . "The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every week, KCAS will bring you another 45-60 minutes of friendly banter between our two finest...

For episode #31 of the "The Weekly Bioanalysis" podcast, Dom and John discuss the technology, history and background on mRNA Vaccines. "The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every week, KCAS will bring you another 45-60 minutes of friendly ban...

The Weekly Bioanalysis celebrates our Silver Episode by featuring our hosts! Dom and John describe each of their unique scientific backgrounds and the experiences that led them to KCAS!. "The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every week, KCAS will bring...

This week Dr. Habibi Goudarzi, Sr Director of Pharmaceutical Discovery at KCAS, and Marsha Luna, Senior Director of Pharmaceutical LC-MS/MS at KCAS join John as we wrap up our three-part series on Discovery, Non-GLP, Non-Clinical Drug Development. This episode, we focus on the way Discovery flows into Pre-Clinical Studies and how KCAS is involved. "The Weekly Bioanalysis" is a podcast de...

This week Dom and John take a little stroll back in time roughly 10 years to discuss the 2010 "Fierce 15" to revisit what they were up to at the time... and where they are now. "The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every week, KCAS will bring...

We've all lived through 2020, We've experienced what it has been like to wonder if there would EVER be an end to the shut-downs, the social distancing, and the wearing of masks. It seemed for months that the idea of a vaccine being made available would never materialize. But the past few weeks have given us renewed hope with a new nearly-approved vaccine or therapeutic announced almost e...

This week Dom and John give us a status update on where the world of pharmaceuticals and biopharmaceuticals are when it comes to drug delivery. They go over a quick history then discuss the various types and where we stand on each. Additionally, they address a few more COVID Vaccine questions that came in after we finished recording the pre-Thanksgiving episode. "The Weekly Bioanalysis"...